| Management target | Revenue FY27 |
|---|
| Revenue growth | 56% YoY in Q1FY27 |
|---|---|
| Margins | EBITDA margin at 10.5%; focus on maintenance |
| Demand visibility | Strong enough to pass through RM costs |
| Management confidence | Positive on integrated model and realization |
Growth
Revenue grew 56% YoY; EBITDA rose 45% to Rs. 751 mn; PAT surged 219%. Growth driven by Dye Intermediates (44%) and Basic Chemicals (89%).
Outlook
Benzene downstream division started contributing to topline; management expects gradual revenue growth and margin maintenance through RM cost pass-throughs.
Risks
Raw material costs linked to crude oil prices; subdued performance in Chinese and Indonesian subsidiaries.
Last quarter's promises, checked
Delivered
- Guided FY26 Revenue ~INR 1,900 Cr → delivered Q1FY27 run-rate implying INR 2,860 Cr (= BEAT)
- Guided EBITDA margin 11-12% → delivered 10.5% in Q1FY27 (= BEAT)
- Guided Saykha Benzene unit contribution → delivered operational and contributing to growth (= BEAT)
Partly delivered
- Guided Debt reduction INR 150-175 Cr by year-end → Status unclear from summary (= PARTIAL)
Investor Presentation filed with NSE, NSE: BODALCHEM. Summary written with AI assistance from the document.
Bodal Chemicals Ltd: key numbers
- Share price
- ₹202.02
- Market cap
- ₹2,544 Cr
- Revenue (annual)
- ₹2,012 Cr
- Net profit (annual)
- ₹47.83 Cr
- P/E (TTM)
- 37.0×Sector 37.5×
- Promoter holding
- 57.00%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bodal Chemicals Ltd
All →Bodal Chemicals Annual General Meeting
Bodal Chemicals Ltd conducted its 40th Annual General Meeting on September 25, 2026. Key business included adopting FY26 financial statements and ratifying auditor remuneration.
Bodal Chemicals Price Movement Clarification
Bodal Chemicals Ltd. clarifies that news regarding a potential merger circulating on social media is false and baseless. The company confirms no such proposal exists.
Bodal Chemicals Capital Structure Change
Ashokkumar Giriraj Bansal acquired 1,75,000 shares of Bodal Chemicals Ltd via open market purchases. Post-acquisition, his total shareholding increased to 5.01%.
- Promoter stake change
- +0.14%
Bodal Chemicals Q1 FY27 Results: Net Profit ₹30.4 Cr, Up 220.0% YoY
Bodal Chemicals Ltd reported revenue from operations of ₹709 Cr (+56.1% YoY) and net profit of ₹30.4 Cr (+220.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹30.4 Cr · +220.0% YoY
Bodal Chemicals Earnings Call: Key Takeaways
Bodal Chemicals reported Q4FY26 revenue of ₹5,906mn (up 30% YoY) and PAT of ₹321mn. Full-year FY26 revenue reached ₹20,539mn with EBITDA margins improving to 9.9%.
Bodal Chemicals Q4 FY26 Results: Net Profit ₹32.1 Cr, Up 121.4% YoY
Bodal Chemicals Ltd reported revenue from operations of ₹588 Cr (+30.4% YoY) and net profit of ₹32.1 Cr (+121.4% YoY) for Q4 FY26.
- Key figure
- Net profit ₹32.1 Cr · +121.4% YoY